key: cord-0886618-p7mwmxxr authors: Prowse, T.; Purcell, T.; Clarys Baia-da-Silva, D.; Sampaio, V.; Marcelo Monteiro, W.; Wood, J.; Mueller, I.; McVernon, J.; Lacerda, M.; Ross, J. title: INFERRED RESOLUTION THROUGH HERD IMMMUNITY OF FIRST COVID-19 WAVE IN MANAUS, BRAZILIAN AMAZON date: 2020-09-27 journal: nan DOI: 10.1101/2020.09.25.20201939 sha: 6b0bbd2e3847e36f1c0287e8686ce6246bb01d79 doc_id: 886618 cord_uid: p7mwmxxr As in many other settings, peak excess mortality preceded the officially reported `first wave' peak of the COVID-19 epidemic in Manaus, Brazil, reflecting delayed case recognition and limited initial access to diagnostic testing. To avoid early information bias, we used detailed age and gender stratified death certificate and hospitalisation data to evaluate the epidemic's trajectory and infer the cause of its decline using a stochastic model. Our results are consistent with heterogenous transmission reducing over time due to the development of herd immunity. Relative to a baseline model that assumed homogenous mixing across Manaus, a model that permitted a small, self-isolated population fraction raised the estimated herd-immunity threshold from 28% to 30% and reduced the final attack rate from 86% to 65%. In the latter scenario, a substantial proportion of vulnerable, older individuals remained susceptible to infection. Given uncertainties regarding the distancing behaviours of population subgroups with different social and economic characteristics, and the duration of sterilising or transmission-modifying immunity in exposed individuals, we conclude that the potential for epidemic outbreaks remains, but that future waves of infection are likely to be much less pronounced than that already experienced. Comparison of population attack rates to inform this question is made challenging by 29 imperfect case ascertainment, compounded by limited diagnostics and overwhelmed health 30 systems, particularly in high incidence settings. Assessment of epidemic activity therefore 31 requires the use of less biased metrics than confirmed case reports. Excess mortality is an 32 objective measure which, with cause-of-death certification, can be used as an indicator of 33 direct and indirect COVID-19 associated mortality 7 . With hospitalisations data, it can inform 34 retrospective estimation of cumulative cases and deaths 8 . 35 Brazil experienced a severe first wave of COVID-19 disease, with mass mortality reported in 36 many states, mainly in the north where seasonality of respiratory infections contributed to 37 higher vulnerability. A socialized health system provided free and global access to tertiary care 38 hospitals, but inequalities might explain different mortality rates in the population 9 . In Manaus, 39 the highly urbanised capital of Amazonas state, the first case of COVID-19 was reported on 13 40 March 2020 10 . By 11 August 2020, 37,597 cases and 2,051 deaths were reported 11 . 41 However, burial and death records indicate far higher mortality than official reports, suggesting 42 late recognition of importation and underreporting. Previous studies have assumed that the first 43 wave in Manaus was significantly mitigated by non-pharmaceutical interventions (NPIs) 12 . 44 While these restrictions may have partly constrained early transmission, local reports indicate 45 that implementation was highly variable 13 . Moreover, a possible role for immunity is suggested 46 by the observation of declining cases and deaths over a period in which restrictions were 47 officially eased. 48 We use death certificate and hospitalisation records to parameterise an epidemiological model 49 of the COVID-19 epidemic in Manaus. The model allows inference of age-and gender-50 stratified infection-fatality ratios to explore evidence for development of herd immunity as a 51 driver of local epidemic resolution, with implications for the ongoing risk posed by SARS-52 CoV-2 to this population. 53 We calculated 3,457 excess deaths in Manaus, Brazil, between 19 March and 24 June 2020 55 (Supplementary Table 1 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint in Manaus died (Figure 1b) . COVID-19 deaths were first reported from 26 March and increased 59 weekly thereafter in keeping with improved access to diagnostics and/or increasing prevalence 60 ( Figure 2 ), comprising 53% of the total excess. Other reported causes of death included 61 respiratory diseases, unattended and unknown causes of mortality, cardiovascular, endocrine 62 and cancer-related mortality, the majority of which were compatible 14 with a clinical diagnosis 63 of COVID-19 or are known comorbidities associated with severe outcomes (Figure 2) . 64 Stochastic transmission models captured the observed peak in excess deaths in late April, 65 including age and gender variation (Figure 3, Supplementary Figures S1, S3 ). The models also 66 captured synchronous peaks in hospitalisations (Figure 3, Supplementary Figures S2, S4 ), 67 although model fit to these data was poorer, potentially reflecting delayed recognition of 68 COVID-19 cases and/or capacity exceedance during the epidemic peak. 69 Despite their different assumptions about the proportion of the Manaus population at risk, the 70 two model scenarios yielded equivalent fits to the data ( Figure 3A, B) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint Early time-series modelling of the COVID-19 epidemic in Brazilian states up to 6 May 2020 86 used an unstructured model informed by state-level mobility indicators and reported deaths 12 . 87 The model inferred population attack rates ranging from 0.13% to 10.6%, for Minas Gerais 88 and Amazonas, respectively, and predicted ongoing epidemic growth throughout May. Other 89 modelled R0 estimates based on reported COVID-19 cases from Amazonas state have similarly 90 anticipated continued growth in cases through the month of June 13 . These models could neither 91 explain nor accurately forecast observations of epidemic decline in Manaus. 92 Our analysis of excess deaths and hospitalisations in Manaus identifies rapid epidemic growth 93 from late March, peaking in late April, with a return to baseline mortality in early June. These 94 age-and gender-stratified models inferred heterogeneous transmission consistent with previous 95 studies of SARS-CoV-1 15 and SARS-CoV-2 16 , and a herd-immunity threshold of around 30%. 96 However, we estimated that this threshold was substantially overshot in Manaus, with resulting 97 attack rates inferred to be 86% and 65% for models that assumed the risk of infection applied 98 to 100% or c. 75% of the population, respectively. 99 Although both models estimated declining SARS-CoV-2 transmission over time due to herd 100 immunity, their implications for the possibility of subsequent waves are qualitatively different. 101 Although there are currently no data to support the assertion that some fraction of the Manaus 102 population self-isolated, we consider the second model is likely more realistic because: (1) the 103 estimated infection-fatality ratios are higher than reported from high-income countries 17 which 104 we anticipate to be plausible; and (2) a population attack rate of 65% is more consistent with 105 recent estimates based on a Manaus blood bank serosurvey 18 which reported the largest 106 increase in seropositivity over the month of April. 107 We focus on Manaus as the epicentre of the COVID-19 epidemic in Amazonas, avoiding 108 conflation of case numbers in this dense city of more than 2 million people with slower 109 growing rural outbreaks across the state 6 . Given known information bias associated with 110 limited early testing capacity, we used excess deaths and hospitalisations as the most 111 objective indicators of epidemic activity presently available. Detailed cause-of-death data 112 support the hypothesis that the majority of excess mortality over this time was COVID-19 113 related. 114 . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint An important caveat is that estimated attack rates accumulate all infections and are agnostic to 115 the presence or degree of symptoms. Severity of the clinical course of COVID-19 is associated 116 with magnitude and persistence of the host immune response 19 . In consequence, our estimates 117 of 'exposure' cannot be directly related to predicted antibody seroprevalence at the end of the 118 first wave 20 . It is reasonably anticipated that population immunity will wane over time, 119 requiring robust memory responses 21 to prevent reinfection or modify the clinical course 22 . 120 Our findings support emerging evidence that population heterogeneity of SARS-CoV-2 121 transmission, attributable to a range of biological and sociological factors, reduces the herd 122 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint Death certificate data from January 2015 to June 2020 were sourced from the Brazilian 148 Ministry of Health Mortality Information System (SIM). Information on age, gender, and 149 cause and date-of-death was recorded. Cause of death was reported using the World Health The ICD-10 codes assigned to each death certificate were aggregated into 7 categories: diseases 167 of the respiratory system (J00-J99), circulatory system (I00-I99), endocrine system (E00-E99), 168 unattended (R98) and unknown cause of death (R99), coronavirus infection (B34.2) and all 169 remaining codes were categorised as 'other'. All analyses were performed using R software. 170 Hospitalisation data for patients admitted to all hospitals (private and public) in Manaus from 172 January 2020 to July 2020 was accessed from the Influenza Surveillance Information System 173 (SIVEP-Gripe). Data entry in this system is compulsory by law. A deidentified line list 174 . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint where , is the basic reproduction number, ! is the mobility covariate and a is the inferred 203 coefficient. We derived the time-series ! by first averaging daily data for five separate indices 204 of community mobility (available as the mobility change relative to baseline for 205 retail/recreation, grocery/pharmacy, parks, transit stations and workplaces, accessed from 206 www.google.com/covid19/mobility), and then smoothed the series with a 7-day moving-207 average smoother. We then assumed the effective reproduction number -.. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint and is the overdispersion parameter, such that smaller values of k represent greater 229 transmission heterogeneity (i.e., the more transmission is due to a small number of people, 230 including by so-called "superspreaders"). Given no previous study has documented strong 231 evidence of different susceptibility between genders, we first generated the expected number 232 of new cases in each age class (regardless of gender), and then assumed gender-specific cases 233 arose from a binomial distribution with probability equal to the proportion of the total 234 susceptible individuals for that age class attributable to each gender. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . 257 Model scenarios. Given no data were available on whether some portion of the Manaus 258 population has been self-isolating since March 2020, we initially fitted a 'baseline' model to 259 death-certificate and hospitalisation data which assumed homogeneous age-structured mixing 260 across the entire Manaus population. We compared these model outcomes to those from a 261 second model that permitted a self-quarantined proportion of the population which could not 262 be exposed to the SARS-CoV-2 virus. Communication with local experts including authors on 263 this paper suggested that more wealthy residents of Manaus had been able to greatly reduce 264 social interactions during the first epidemic wave and avoid exposure to the virus. We reviewed 265 detailed socio-demographic data on Manaus 35 , but were not able to source quantitative 266 estimates of the relevant population fraction. However, we considered that this would not 267 exceed the upper 2 income quintiles (40%) of the population but was likely to be greater than is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint Figure S2 . Baseline model fits to hospitalisations data for all 32 age and gender classes. 388 Shown are the model-inferred expected hospitalisation rate (lines) ± 95% credible intervals 389 (ribbons) and the hospitalisations data used for model fitting (points). 390 . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint Figure S4 . The fit of Model 2 to hospitalisations data for all 32 age and gender classes. 396 Shown are the model-inferred expected hospitalisation rate (lines) ± 95% credible intervals 397 (ribbons) and the hospitalisations data used for model fitting (points). 398 . CC-BY-ND 4.0 International license It is made available under a perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted September 27, 2020. . https://doi.org/10.1101/2020.09.25.20201939 doi: medRxiv preprint The scale and dynamics of COVID-273 19 epidemics across Australia looks to be finally beating its second wave of coronavirus Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-279 Infected Pneumonia High Contagiousness and Rapid Spread of Severe Acute Respiratory 281 Herd immunity thresholds for SARS-CoV-2 estimated from 283 unfolding epidemics Brazil's policies condemn Amazonia to a second wave of COVID